ArticleJACC. Case reports2026

Mavacamten Reduces LVOT Obstruction Risk, Enabling Transseptal Mitral Valve-in-Valve for Degenerated Bioprosthesis.

Alexander Hoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.